Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

AstraZeneca
Harvard Business School
Moodys
Mallinckrodt
Colorcon
Boehringer Ingelheim

Last Updated: December 5, 2019

DrugPatentWatch Database Preview

Actavis Inc Company Profile

See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for ACTAVIS INC, and what generic and branded alternatives to ACTAVIS INC drugs are available?

ACTAVIS INC has five approved drugs.



Summary for Actavis Inc
US Patents:0
Tradenames:5
Ingredients:5
NDAs:5
Patent Litigation for Actavis Inc: See patent lawsuits for Actavis Inc

Drugs and US Patents for Actavis Inc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Inc GEMCITABINE HYDROCHLORIDE gemcitabine hydrochloride INJECTABLE;INJECTION 204549-003 Apr 11, 2016 AP RX No No   Start Trial   Start Trial
Actavis Inc DOXORUBICIN HYDROCHLORIDE doxorubicin hydrochloride INJECTABLE;INJECTION 203622-002 Jun 27, 2014 AP RX No No   Start Trial   Start Trial
Actavis Inc DEXMEDETOMIDINE HYDROCHLORIDE dexmedetomidine hydrochloride INJECTABLE;INJECTION 204686-001 Oct 17, 2016 AP RX No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Merck
McKesson
AstraZeneca
Express Scripts
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.